Different FDA Regs For Devices, Drugs Rule Preemption

Law360, New York (November 10, 2009, 5:52 PM ET) -- Over the past two years, the United States Supreme Court has had two opportunities to address and add to the jurisprudence in the area of federal preemption of state law claims regarding allegedly defective medical devices and prescription drugs, which are both regulated by the U.S. Food and Drug Administration.

In Riegel v. Medtronic Inc., 128 S.Ct. 999 (U.S. 2008), the United States Supreme Court held that the Medical Device Act's preemption clause expressly preempts state law claims challenging the safety and effectiveness of a medical...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles